Health & Biotech
Health & Biotech
MGC Pharma US partnership validated after receiving first payment for US$24m order of CimetrA
Health & Biotech
ASX Health: 4D Medical jumps 16pc on lungs device rollout, Proteomics up 10pc on UK deal
Health & Biotech
Paul Hopper on whether his new venture Radiopharm Theranostics will be a takeover target, and the keys to biotech success
Health & Biotech
ASX Health: Twiggy Forrest’s investment fund takes a stake in this ASX cannabis stock
Health & Biotech
Prescient bolsters board with experienced and leading figures in CAR-T therapy
Health & Biotech
ScoPo’s Powerplays: Investors look to Healthcare for ESG exposure, and Volpara is the poster child
Health & Biotech
Apiam expands presence in national animal health market with Equine Clinic acquisition
Health & Biotech
ASX Health Stocks: Apiam and Trajan on acquisition trail, Immutep provides updates on Phase 2 trials
Health & Biotech
Stock Insiders: InteliCare smart sensor and AI technology is assisting care providers and their families
Health & Biotech
PharmAust marches ahead to Phase 1 trials on COVID-19 and motor neurone disease
Health & Biotech
ASX Health Stocks: Amplia eyes human trials for pancreatic cancer drug
Health & Biotech
ASX Health Stocks: Imugene joins forces with Merck and Pfizer for Phase 2 trial on gastric cancer
Health & Biotech
Singular Health Group forms 50/50 JV to commercialise VR software for mine optimisation
Health & Biotech
Mesoblast and the ASX’s other big biotechs have intrigued investors this year; here’s what’s in store next
Health & Biotech
EZZ to use strong FY21 results to expand growth in international markets
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.